| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.6B | $4.6B | $1.1B | $7.7B | $1.7B | $1.5B | $1.4B |
| Cost of Revenue | $2.5B | $2.5B | $2.7B | $2.8B | $4.9B | $3.9B | $3.7B | $3.5B |
| Gross Profit | — | — | — | $0.5B | — | $0.6B | $0.5B | $0.5B |
| R&D Expense | — | — | — | — | — | — | $0.0B | $0.1B |
| SG&A Expense | $1.3B | $1.2B | $1.2B | $1.1B | $1.6B | $1.3B | $1.3B | $1.2B |
| Operating Income | $0.5B | $0.7B | $0.6B | $0.8B | $1.1B | $0.2B | $0.2B | $0.1B |
| Net Income | $0.3B | $0.5B | $0.4B | $0.7B | $0.8B | $0.6B | $0.4B | $0.4B |
| EPS (Basic) | $2.48 | $3.78 | $3.19 | $5.27 | $5.62 | $1.18 | $0.75 | $0.60 |
| EPS (Diluted) | $2.47 | $3.75 | $3.17 | $5.23 | $5.54 | $1.16 | $0.74 | $0.60 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B | $6.6B | $6.6B | $6.1B | $7.9B | $7.4B | $6.3B | $6.0B |
| Current Assets | $2.0B | $2.0B | $2.0B | $2.5B | $2.7B | $2.2B | $1.9B | $1.7B |
| Cash & Equivalents | $0.3B | $0.4B | $0.4B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B |
| Total Liabilities | $4.1B | $4.1B | $4.3B | $4.0B | $4.9B | $4.6B | $3.9B | $3.8B |
| Current Liabilities | $1.1B | $1.6B | $1.2B | $1.5B | $2.0B | $1.3B | $1.4B | $1.5B |
| Stockholders' Equity | — | — | — | — | — | $2.8B | $2.4B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.7B | $1.1B | $0.6B | $0.7B | $0.8B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.1B | $-0.3B | $-1.0B | $-0.5B | $-0.2B | $-0.9B | $-0.1B | $-0.6B |
| Capital Expenditures | $0.1B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.2B |
| Financing Cash Flow | $-0.5B | $-0.4B | $-0.3B | $0.1B | $-0.4B | $0.1B | $-0.4B | $-0.0B |